Bias in retrospective analyses of biomarker effect using data from an outcome-adaptive randomized trial.
- Published in:
- Clinical Trials, 2019, v. 16, n. 6, p. 599, doi. 10.1177/1740774519875969
- By:
- Publication type:
- Article
Works matching IS 17407745 AND DT 2019 AND VI 16 AND IP 6
Results: 15
1
2
Informal professionalization of healthy participants in phase I clinical trials in Russia.
- Published in:
- Clinical Trials, 2019, v. 16, n. 6, p. 563, doi. 10.1177/1740774519877851
- By:
- Publication type:
- Article
3
Commentary on Zvonareva et al.: Exploring the many meanings of "professional" in research participation.
- Published in:
- Clinical Trials, 2019, v. 16, n. 6, p. 571, doi. 10.1177/1740774519877850
- By:
- Publication type:
- Article
4
Rejoinder.
- Published in:
- Clinical Trials, 2019, v. 16, n. 6, p. 613, doi. 10.1177/1740774519875971
- By:
- Publication type:
- Article
5
Commentary on Ji et al: Sub-optimal illustration of response adaptive randomization.
- Published in:
- Clinical Trials, 2019, v. 16, n. 6, p. 610, doi. 10.1177/1740774519875968
- By:
- Publication type:
- Article
6
Stepped-wedge trials should be classified as research for the purpose of ethical review.
- Published in:
- Clinical Trials, 2019, v. 16, n. 6, p. 580, doi. 10.1177/1740774519873322
- By:
- Publication type:
- Article
7
Evaluation of irrational dose assignment definitions using the continual reassessment method.
- Published in:
- Clinical Trials, 2019, v. 16, n. 6, p. 665, doi. 10.1177/1740774519873316
- By:
- Publication type:
- Article
8
A high-volume, low-cost approach to participant screening and enrolment: Experiences from the T4DM diabetes prevention trial.
- Published in:
- Clinical Trials, 2019, v. 16, n. 6, p. 589, doi. 10.1177/1740774519872999
- By:
- Publication type:
- Article
9
Sequential or combined designs for Phase I/II clinical trials? A simulation study.
- Published in:
- Clinical Trials, 2019, v. 16, n. 6, p. 635, doi. 10.1177/1740774519872702
- By:
- Publication type:
- Article
10
Accrual Prediction Program: A web-based clinical trials tool for monitoring and predicting accrual for early-phase cancer studies.
- Published in:
- Clinical Trials, 2019, v. 16, n. 6, p. 657, doi. 10.1177/1740774519871474
- By:
- Publication type:
- Article
11
Bayesian clinical trials at The University of Texas MD Anderson Cancer Center: An update.
- Published in:
- Clinical Trials, 2019, v. 16, n. 6, p. 645, doi. 10.1177/1740774519871471
- By:
- Publication type:
- Article
12
Design and monitoring of survival trials based on restricted mean survival times.
- Published in:
- Clinical Trials, 2019, v. 16, n. 6, p. 616, doi. 10.1177/1740774519871447
- By:
- Publication type:
- Article
13
Noninferiority trials with nonadherence to the assigned randomized treatment.
- Published in:
- Clinical Trials, 2019, v. 16, n. 6, p. 673, doi. 10.1177/1740774519868479
- By:
- Publication type:
- Article
14
A win ratio approach to the re-analysis of Multiple Risk Factor Intervention Trial.
- Published in:
- Clinical Trials, 2019, v. 16, n. 6, p. 626, doi. 10.1177/1740774519868233
- By:
- Publication type:
- Article
15
Public views regarding the responsibility of patients, clinicians, and institutions to participate in research in the United States.
- Published in:
- Clinical Trials, 2019, v. 16, n. 6, p. 574, doi. 10.1177/1740774519858917
- By:
- Publication type:
- Article